Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
80%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Completed(1)
Other(1)

Detailed Status

Not yet recruiting2
Recruiting1
Completed1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

recruiting120%
not_yet_recruiting240%
completed120%
unknown120%

Recent Activity

1 active trials
Showing 5 of 5
not_yet_recruitingnot_applicable

Enumeration and Functional Analysis of Circulating Tumor Cells for Homologous Recombination: a Prospective Single-center Study on Advanced/Metastatic Solid Tumors

NCT07555600
not_yet_recruitingnot_applicable

Impact of Androgen Signaling on the Composition of the Immune Microenvironment in Glioblastomas

NCT07472387
recruiting

Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors

NCT05831631
completednot_applicable

Analysis of Circulating Tumor Markers in the Blood (ALCINA)

NCT02866149
unknownnot_applicable

ChEmo-Genomics Based Treatment of Acute Myeloid Leukemia

NCT02619071

Clinical Trials (5)

Showing 5 of 5 trials
NCT07555600Not Applicable

Enumeration and Functional Analysis of Circulating Tumor Cells for Homologous Recombination: a Prospective Single-center Study on Advanced/Metastatic Solid Tumors

Not Yet Recruiting
NCT07472387Not Applicable

Impact of Androgen Signaling on the Composition of the Immune Microenvironment in Glioblastomas

Not Yet Recruiting
NCT05831631

Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors

Recruiting
NCT02866149Not Applicable

Analysis of Circulating Tumor Markers in the Blood (ALCINA)

Completed
NCT02619071Not Applicable

ChEmo-Genomics Based Treatment of Acute Myeloid Leukemia

Unknown

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5